Benkowitz Michael's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jan 7, 2025
- Accession no.
- 0001562180-25-000239
- Filed
- Jan 7, 2025
- Trade date
- Jan 6, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 13 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.55M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benkowitz MichaelCIK 0001673232 | Officer (PRESIDENT AND COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | Common Stock | MOption exerciseAcquired | +7,500 | $111.00 | +$832,500 | 7,500 | Indirect | |
| Jan 6, 2025 | Common Stock | SSaleDisposed | −1,022 | $353.60 | −$361,379.2 | 6,478 | Indirect | |
| Jan 6, 2025 | Common Stock | SSaleDisposed | −3,620 | $354.59 | −$1,283,615.8 | 2,858 | Indirect | |
| Jan 6, 2025 | Common Stock | SSaleDisposed | −1,458 | $355.30 | −$518,027.4 | 1,400 | Indirect | |
| Jan 6, 2025 | Common Stock | SSaleDisposed | −419 | $356.61 | −$149,419.59 | 981 | Indirect | |
| Jan 6, 2025 | Common Stock | SSaleDisposed | −681 | $357.54 | −$243,484.74 | 300 | Indirect | |
| Jan 6, 2025 | Common Stock | SSaleDisposed | −300 | $358.32 | −$107,496 | 0 | Indirect | |
| Jan 6, 2025 | Common Stock | MOption exerciseAcquired | +2,500 | $111.00 | +$277,500 | 2,500 | Indirect | |
| Jan 6, 2025 | Common Stock | SSaleDisposed | −700 | $353.91 | −$247,737 | 1,800 | Indirect | |
| Jan 6, 2025 | Common Stock | SSaleDisposed | −1,180 | $355.04 | −$418,947.2 | 620 | Indirect | |
| Jan 6, 2025 | Common Stock | SSaleDisposed | −200 | $355.79 | −$71,158 | 420 | Indirect | |
| Jan 6, 2025 | Common Stock | SSaleDisposed | −220 | $357.26 | −$78,597.2 | 200 | Indirect | |
| Jan 6, 2025 | Common Stock | SSaleDisposed | −200 | $358.30 | −$71,660 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | Common | MOption exerciseDisposed | −2,500 | $0.00 | $0 | 22,000 | Indirect | |
| Jan 6, 2025 | Common | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 59,679 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.